top of page
Image by Sangharsh Lohakare
cell-visual-2.jpg

Life Science Insights at Your Finger Tips!

Sign up to our newsletter, to get access to the latest life science industry insights, thought leadership content and exclusive content tips and ideas.

By submitting this form, you accept our Privacy Policy & Cookie Policy.

What is Pharmacovigilance and Why Is It Important

pharmaceutical medicine pills

Keeping patients safe is at the core of the drug development process; this is where pharmacovigilance comes into play. Pharmacovigilance is a system that works continuously in the background, monitoring the safety of pharmaceuticals, ultimately ensuring patients are as safe as possible. In this blog, we will outline the best practices in pharmacovigilance, why this is essential for drug safety, and how pharmacovigilance services can help you stay compliant and patient-focused.


What Is Pharmacovigilance?

Pharmacovigilance is the science and activities focused on detecting, assessing, understanding, and preventing adverse effects of medicines and vaccines. These adverse effects are known as adverse drug reactions (ADRs), which can range from mild issues like nausea and headaches to more serious reactions, such as those affecting the liver and skin. 


Why was Pharmacovigilance created 

The importance of pharmacovigilance was brought to light after several drug safety incidents, like the thalidomide disaster in the 1960s, which caused thousands of severe birth defects when taken by pregnant women. This led to the creation of vital pharmacovigilance programs worldwide, like the UK’s Yellow Card reporting system and the World Health Organisation's international drug monitoring programme. Together, these systems ensure a global approach to drug safety, helping to protect every patient. 

Why Is Pharmacovigilance Important?

Protecting patients

Protecting patients is at the heart of drug development. Early detection of safety issues through continuous monitoring and reporting systems plays a huge role in preventing pharmaceutical safety risks. This makes sure any issues are addressed quickly to protect as many patients as possible.

Improving Public Health

Data-driven decision-making is changing the game in public health. By harnessing the power of real-time data, regulatory authorities and pharmaceutical companies can now detect ADRs, identify emerging safety signals, and assess risk factors much earlier. This helps ensure the right evidence-based steps are taken quickly, keeping patients safe and making sure the benefits of medicines outweigh the risks.

Ensuring Regulatory Compliance

In the world of pharmaceuticals, regulatory compliance is essential for patient protection. Pharmaceutical companies are required to follow strict global guidelines to ensure their products are safe, effective, and of high quality. This means keeping detailed records, running strong quality control processes, and staying on top of changing regulations.

Building Trust in Medicine

Trust between patients and healthcare providers starts with transparency. When organisations openly share information about safety practices, outcomes, and how decisions are made, it instills confidence that they’re committed to putting patient well-being first. 


What are Good Pharmacovigilance Practices (GVP)?

Good Pharmacovigilance Practices (GVP) are a set of official guidelines created by regulatory agencies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). These practices are in place to make sure medicines are continually assessed for safety throughout the drug development and monitoring process.

Here are some key GVPs:

Risk Management Systems - These help identify, assess, and minimise risks associated with a medicine, which helps pinpoint any issues early and protect patients

Pharmacovigilance System Master File (PSMF) - This is a comprehensive document that outlines how a company manages drug safety, essentially acting as a blueprint for their entire pharmacovigilance system

Periodic Safety Update Reports (PSURs) - These regular reports provide updated information on the safety profile of a drug, helping regulators assess the risk-benefit ratio of a product

Why is GVP so important?

GVP is the foundation of responsible, transparent, and ethical drug safety monitoring and is essential for maintaining trust in the pharmaceutical industry. Sticking to these guidelines means:

  • Staying compliant with international regulations

  • Being ready for audits or inspections

  • Protecting the health and well-being of patients

The Role of Pharmacovigilance Services

Pharmacovigilance services support biotech, pharmaceutical, and life science startup companies, ensuring they stay on top of drug safety, from clinical trials all the way through to real-world use.

What Do Pharmacovigilance Services Include? 

Pharmacovigilance is all about monitoring, detecting, and managing risks related to pharmaceuticals. Here are some of the key aspects of pharmacovigilance services:

Case Processing - Collecting, reviewing, and managing reports of adverse events Signal Detection - Identifying patterns that could indicate new safety concerns Literature Screening -  Regularly reviewing medical and scientific literature to identify and keep up to date with any published safety information Regulatory Reporting -  Ensuring required safety reports are submitted accurately and on time to health authorities like the FDA or EMA

Benefits of Outsourcing Pharmacovigilance

Expertise - Access to specialists with knowledge of global safety regulations Scalability - Services can grow as your pipeline grows, without the need to hire a full team right away Compliance - Stay audit-ready and be confident with meeting regulatory requirements and deadlines

Challenges and Future Pharmacovigilance 

Pharmacovigilance is evolving fast. With huge amounts of data from electronic health records, social media, and real-world evidence, one major challenge is data overload. In addition to this, global regulatory differences can make safety reporting complex. To combat these challenges, efforts are being made to harmonise regulatory rules across countries, and AI and automation are now widely being adopted to detect safety issues faster and more accurately. 

The nature of pharmacovigilance is forever evolving, but it is ultimately moving in the direction of a more proactive, tech-driven, and globally connected approach, which will make medicines safer for everyone. 


Conclusions

Pharmacovigilance is not just a regulatory requirement, it’s a cornerstone of patient safety. From detecting rare adverse events to ensuring long-term safety monitoring, pharmacovigilance helps build trust in therapies and improves patient safety. For startups and researchers, prioritising pharmacovigilance early will create a smoother path through approvals and will give confidence to both investors and regulators. 


At Co-Labb, our PhD-educated writers are highly experienced in regulatory writing and pharmacovigilance-aligned services. Whether you’re preparing an IND or scaling up post-marketing surveillance, contact us today to help you stay compliant and patient-focused throughout all of your pharmacovigilance needs.


bottom of page